Jesduvroq (daprodustat) – New drug approval
February 1, 2023 - The FDA announced the approval of GSK’s Jesduvroq (daprodustat), for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.
Download PDF
